Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-24 @ 5:48 PM
NCT ID: NCT01526668
Eligibility Criteria: Inclusion Criteria: * Women between 18 and 60 years of age. * Women who are scheduled for vaginal or abdominal total or subtotal hysterectomy for benign gynecological diseases (including cervical dysplasia). * Women who understand and speak Swedish fluently. * Women who gives signed informed consent to participate in the study. * Women who have access to a telephone and/or internet. Exclusion Criteria: * Women where the hysterectomy is carried out in association with surgery for genital prolapse * Women with genital malignancies (does not include cervical dysplasia). * Women where the operation is planned or expected to comprise more than the hysterectomy with or without unilateral salpingooophorectomy and appendectomy en passant. * Women with previous bilateral salpingooophorectomy. * Women who are physically disabled to a degree so that mobilization postoperatively cannot be expected as for a normal individual. * Women who are mentally disabled to a degree so she cannot complete the forms in the study or understand the tenor of the participation or it is considered doubtful from an ethical point of view to participate. * Women with psychiatric disease or is on medication for severe psychiatric disease so that the physician consider participation in the study unsuitable. * Women with current drug or alcohol abuse.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 60 Years
Study: NCT01526668
Study Brief:
Protocol Section: NCT01526668